hers semaglutide side effects Questions about & compound : r/HersWeightloss Semaglutide Side Effects: Common vs

Both compounds produced meaningful waist circumference reductions, but tirzepatide was superior on both endpoints at week 72 [10]

This involves strategies like: Identifying and managing emotional triggers for unhealthy eating Building sustainable exercise routines that fit your lifestyle Developing healthy coping mechanisms for stress and fatigue Creating a supportive environment that encourages healthy habits The Winning Formula: Combining Forces for Success The most effective approach lies in combining the power of GLP-1s with a robust behavior change program

The increasing prevalence of obesity worldwide and its associated pressure on healthcare systems, along with the reputation of GLP-1 drugs for inducing significant weight loss (approximately 1525+%, significantly higher than previous generations of obesity drugs), are driving GLP-1 drug expansion into new markets like China

Key questions to discuss include: Whether you meet NHS criteria for GLP-1 prescription (type 2 diabetes or obesity with complications) The evidenceor lack thereoffor GLP-1 use specifically in Hashimoto's management Potential interactions between GLP-1 medications and thyroid hormone replacement How GLP-1 therapy might affect your thyroid function monitoring schedule Alternative evidence-based approaches to managing metabolic symptoms in Hashimoto's The costs and practicalities of private prescription if NHS funding is not available Contraception requirements if you are of childbearing potential (GLP-1 medications should be avoided in pregnancy and breastfeeding) Your GP may recommend optimising your current thyroid management first , ensuring your levothyroxine dose is appropriate and that you are not over- or under-replaced

Costea et al., 2018), each classified by a dominant genus: Bacteroides (Enterotype 1) and Prevotella (Enterotype 2) and a third Firmicutes dominant cluster with Ruminococcus (Enterotype 3) (Costea et al., 2018)